Chargement en cours...
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
PET using (18)F-FDG for treatment monitoring in patients with lymphoma is one of the most well-developed clinical applications. PET/CT is nowadays used during treatment to assess chemosensitivity, with response-adapted therapy given according to ‘interim’ PET in clinical practice to adults and child...
Enregistré dans:
| Publié dans: | Eur J Nucl Med Mol Imaging |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5541086/ https://ncbi.nlm.nih.gov/pubmed/28411336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3690-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|